Cargando…
Subanaesthetic dose of esketamine during induction delays anaesthesia recovery a randomized, double-blind clinical trial
BACKGROUND: Esketamine is an antagonist of the N-methyl-D-aspartate receptor (NMDA receptor) that is widely used for multimodal analgesia. In addition to analgesia, sedation is another important effect of esketamine. However, data are limited regarding the sedation effect of esketamine during genera...
Autores principales: | Zhang, Cao, He, Jiangqin, Shi, Qinye, Bao, Fangping, Xu, Jianhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082902/ https://www.ncbi.nlm.nih.gov/pubmed/35534825 http://dx.doi.org/10.1186/s12871-022-01662-0 |
Ejemplares similares
-
A Comparison of Intranasal Dexmedetomidine, Esketamine or a Dexmedetomidine-Esketamine Combination for Induction of Anaesthesia in Children: A Randomized Controlled Double-Blind Trial
por: Lu, Xinlei, et al.
Publicado: (2022) -
Effect of Subanaesthetic Dose of Ketamine on Pneumoperitoneal Response and Clinical Recovery in Patients Undergoing Laparoscopy
por: Rajarajan, Swaminathan Veerasamy, et al.
Publicado: (2022) -
Effects of the Different Doses of Esketamine on Postoperative Quality of Recovery in Patients Undergoing Modified Radical Mastectomy: A Randomized, Double-Blind, Controlled Trial
por: Zhu, Min, et al.
Publicado: (2022) -
Neonatal administration of a subanaesthetic dose of JM-1232(−) in mice results in no behavioural deficits in adulthood
por: Iwanaga, Koji, et al.
Publicado: (2021) -
Effects of the Different Doses of Esketamine on Postoperative Quality of Recovery in Patients Undergoing Modified Radical Mastectomy: A Randomized, Double-Blind, Controlled Trial [Letter]
por: Cheng, Yi, et al.
Publicado: (2023)